Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy
Latest Information Update: 12 Sep 2023
At a glance
- Drugs Leuprorelin (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms ADOPT
- 30 Jun 2020 New trial record